CERO

Healthcare Biotechnology

CERo Therapeutics Holdings, Inc.

$0.01

-0.00 -9.09% today

Price History

Not enough data

Key Stats

Market Cap

716,309.904

Avg Volume

587,759

P/E (TTM)

0.00

EPS

$40.34

52W High

$5.66

52W Low

$0.01

Div. Yield

0.0%

Valuation

Forward P/E

-0.00

P/B Ratio

-0.02

EV/EBITDA

-0.96

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(279.0%)

Liquidity & Leverage

Current Ratio

0.05

Quick Ratio

0.03

Total Cash

862,756

Total Debt

15.94M

About

CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.